Clinical trial of telerehabilitation training and intelligent evaluation system

A clinical trial to verify the effectiveness and safety of the telerehabilitation training and evaluation system in guiding the recovery of limb motor function in stroke patients with limb motor dysfunction

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200061310

Enrollment

Unknown

Registered

2022-06-20

Start date

2019-12-30

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

stroke

Interventions

Experimental group :Rehabilitation training and rehabilitation evaluation through telerehabilitation training and intelligent evaluation system

Control group:Clinical routine occupational therapy and physician Fugl-Meyer assessment

Eligibility

Sex/Gender

All

Age

33 Years to 73 Years

Inclusion criteria

Inclusion criteria: 1. Stroke patients diagnosed by CT or MRI within 90 days; 2. Age between 30-75 years old, male or female; 3. Limb motor dysfunction caused by 15-180 days after the onset of stroke (recovery period)(hemiplegia motor function evaluation Brunnstrom upper limb and/or lower limb classification is II-VI stage), rehabilitation patients with stable disease; 4. Have a clear understanding and be able to follow the research plan; 5. Subjects can understand the purpose of the research, show sufficient compliance with the research program, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Significant cognitive and consciousness impairment so that the Fugl-Meyer measurement cannot be completed; 2. Other significant limb lesions, such as fractures, severe arthritis, amputation, etc.; 3. Formation of limb joint contractures; 4. Disabled patients specified by law (such as blindness, deafness, muteness, intellectual disability, mental disability, physical disability); 5. Patients with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system, mental illness; 6. Women of childbearing age with positive urine pregnancy test results; 7. Those who have participated in clinical trials of other drugs/devices within 90 days before screening; 8. Those who carry active metal instruments in the body, such as cardiac pacemakers; 9. Other situations in which the investigator considers it inappropriate to participate in this trial.

Design outcomes

Primary

Measure	Time frame
Fugl-Meyer score;	—

Secondary

Measure	Time frame
Rehabilitation assessment time;	—

Countries

China

Contacts

Public ContactLiu Zhaohui

Tangdu Hospital Airforce Medicine University

5548986@qq.com+86 19962651024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026